Wetenschappelijk tijdschrift voor psychiaters, artsen in opleiding tot psychiater en andere geïnteresseerden
Edit

Issue

Previous issues

Editorial

Herstelondersteuning, de behandel- relatie en het risico van onder­behandeling

ISSUE 2021/3
8 maart 2021
M.B. de Koning
Scientific news

Medicatie / COVID-19 in ’t kort

ISSUE 2021/3
8 maart 2021
Wekelijks verschijnen er talloze nieuwe publicaties in de wetenschappelijke psychiatrie-vakbladen. Voor de psychiater (i.o.) uit de dagelijkse praktijk maakt het Tijdschrift voor Psychiatrie in deze rubriek een selectie van recent verschenen publi...Read more
Psychiatry and COVID-19

The influence of corona related factors on acute psychiatric admissions

ISSUE 2021/3
8 maart 2021
K.B. Koopmans, G.M. Jalink, J.W. van der Paardt, J. Peen, J.M. van Bruggen

Background Since the COVID-19 outbreak there are warnings for an increase of psychological complaints in the general population and in psychiatric patients.
Aim To gain insight in corona associated factors that can provoke psychiatric decompe...

Read more
Commentary

Zorgstandaarden voor patiënten met PTSS en dissociatieve stoornissen

ISSUE 2021/3
8 maart 2021
T.J.M. Ingenhoven
Original research

Intensive home treatment (IHT): indication criteria for children and adolescents

ISSUE 2021/3
8 maart 2021
L. van den Boogaard, A. Popma, M. van der Hoeven, M. van den Boer, P. Bokhorst, A. Heerma, M. van der Meer, J. Steenmeijer, B. van der Stegen, T.J. Dekkers

Background Intensive home treatment (IHT) is an intervention that provides intensive psychiatric (crisis) care in the home environment.
Aim To formulate indication criteria for IHT in children and adolescents, to improve assessment and to red...

Read more
Original research

Dutch medical disciplinary law cases concerning psychiatry, 2015-2019

ISSUE 2021/3
8 maart 2021
F.L. Gerritse, R.J. Duvivier

Background The aim of medical disciplinary law (as part of the Dutch law ‘Wet BIG’) is to safeguard the quality of professional practice in the health services. Quantitative data about Dutch medical disciplinary law is sparse: little is known abo...

Read more
Review article

Between response and resistance: pseudo-resistance during treatment of major depressive disorder

ISSUE 2021/3
8 maart 2021
G. Steegen, K.C.E.E.R. Catthoor, B.G.C. Sabbe, T. Dreesen, F. Vandendriessche, J. Detraux

Background Although the efficacy of antidepressants has been clearly established, 30-60% of patients with major depressive disorder (MDD) appear to have a poor response. However, many patients labeled with treatment-resistant depression actually ...

Read more
Essay

Patient-tailored approach in tertiary care expert centres using individual dynamic network analysis

ISSUE 2021/3
8 maart 2021
J.H. Houtveen, L. de Vroege, J.F. van Eck van der Sluijs, I. Elfeddali, A.C. Videler, C.H. Lunter, W.J. Kop, R. Geenen

Background Patients with mental health disorders often have difficulty perceiving associations between multiple symptoms, such as inter-relations between somatic and psychological symptoms. This difficulty may be particularly challenging in patie...

Read more
Essay

Assertive Treatment as a regular function within mental health

ISSUE 2021/3
8 maart 2021
C.L. Mulder, A. Liégeois, M. van Vugt, K. Westen, P. Delespaul, H. Kroon

Background The setting for providing assertive treatment (AT) has changed during the last 30 years in The Netherlands from assertive community treatment (ACT) and flexible assertive community treatment (FACT) to municipalities. The provision of A...

Read more
Clinical practice

Hyperprolactinemia and antipsychotics: it’s not always what it seems to be

ISSUE 2021/3
8 maart 2021
A.E. Brandsma, R.H.A. van der Doelen, W.A. Ester

Hyperprolactinemia is a relatively frequent laboratory abnormality (30-80%) as a result of antipsychotics and a reason to reduce or stop them. We describe two youngsters with autism spectrum disorder whose hyperprolactinemia was based on a false...

Read more
Clinical practice

Obsessive-compulsive symptoms as a side effect of infliximab – a case report

ISSUE 2021/3
8 maart 2021
N. Wirix, C. Bervoets

A 35-year-old man with no psychiatric history develops compulsive complaints after the start of infliximab. Given the coincidence of initiating this drug and the occurrence of these psychological symptoms, the dose of infliximab is reduced, whic...

Read more
Abstract

Depotantipsychotica en het risico op een recidiefpsychose

ISSUE 2021/3
9 maart 2021
H.W. Heetla, S.K. Spoelstra, H. Knegtering
Dutch-Flemish research

Afbouw van antidepressiva tijdens de zwangerschap met preventieve cognitieve therapie

ISSUE 2021/3
8 maart 2021
N.M. Molenaar
Psychiatry of the future

Effectiviteit van digitale psychologische interventies in lage- en middeninkomenslanden

ISSUE 2021/3
8 maart 2021
J.K. Tijdink
Letter to the editor

Reactie op: ‘De toekomst van precisiepsychiatrie’

ISSUE 2021/3
8 maart 2021
M. Calmeyn
Letter to the editor

Reactie op: ‘Suïcide bij mensen met een lichte verstandelijke beperking’

ISSUE 2021/3
8 maart 2021
M. Otter, D. Cohen